Valemetostat (DS-3201) Mechanism of Action: EZH2 Inhibition in T-cell Research

Valemetostat (DS-3201) MOA:Targeting EZH2 / PRC2 Pathway for T-cell Lymphoma

🎯 check Valemetostat (DS-3201) product page

Valemetostat is a potent dual EZH1/2 inhibitor. It affects p53/p21 signaling by reducing H3K27me3, to inhibit tumor growth.

Primary Applications and Mechanism of Action